| scholarly article | Q13442814 |
| case report | Q2782326 |
| P50 | author | Alessandro Russo | Q56528563 |
| Tindara Franchina | Q126974694 | ||
| Giuseppina Rosaria Rita Ricciardi | Q126974695 | ||
| Giuseppa Ferraro | Q126974701 | ||
| P2093 | author name string | Vincenzo Adamo | |
| P2860 | cites work | Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer | Q26824799 |
| Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. | Q27824766 | ||
| Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer | Q27851691 | ||
| Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer | Q29616112 | ||
| Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials | Q33293618 | ||
| Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer | Q34393640 | ||
| Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review). | Q34687074 | ||
| Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study | Q34886764 | ||
| Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: disposition kinetics and pharmacology distinct from solvent-based paclitaxel | Q34996710 | ||
| Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier. | Q35608531 | ||
| The biology of brain metastases-translation to new therapies | Q35676602 | ||
| Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab | Q36862845 | ||
| Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials | Q36885522 | ||
| Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer. | Q37442881 | ||
| Brain metastases as preventive and therapeutic targets | Q37862581 | ||
| CNS metastases in breast cancer: old challenge, new frontiers | Q38168168 | ||
| Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer | Q42463524 | ||
| Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer | Q44176007 | ||
| Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer | Q48142933 | ||
| 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. | Q53243856 | ||
| Extended survival in women with brain metastases from HER2 overexpressing breast cancer | Q81399965 | ||
| A phase II study of weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab in metastatic breast cancer | Q84097279 | ||
| Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer | Q84529291 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | trastuzumab | Q412616 |
| brain metastasis | Q1620196 | ||
| P304 | page(s) | 289-294 | |
| P577 | publication date | 2015-02-02 | |
| P1433 | published in | OncoTargets and Therapy | Q7092081 |
| P1476 | title | Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases | |
| P478 | volume | 8 |
| Q90614161 | A Novel Paclitaxel Conjugate with Higher Efficiency and Lower Toxicity: A New Drug Candidate for Cancer Treatment |
| Q38780817 | Effect of Combined Treatment Using Wilfortrine and Paclitaxel in Liver Cancer and Related Mechanism. |
| Q47839509 | Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review |
| Q89867988 | Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine |
| Q37123227 | Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer |
| Q38647544 | Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient's Quality of Life: A Single-Center, 10-Year Experience from Southern Italy |
Search more.